NCT03778931 2025-09-15EMERALDStemline Therapeutics, Inc.Phase 3 Completed478 enrolled 16 charts 1 FDA
NCT05512364 2025-08-19TREAT ctDNAEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 3 Recruiting220 enrolled